This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract, valued at $249,723.00, was awarded to Detroit R&D, Inc., a minority-owned, economically disadvantaged, woman-owned small business located in Bloomfield Hills, Michigan. The contract is for research and development of a "Multiplex Label-Free Nanowell Technology...
This definitive cost-plus-fixed-fee contract for $724,601.63 was awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Accel Diagnostics, LLC, doing business as ADX Diagnostic Lab, on November 19, 2018. The contract is associated with SBIR Topic 97, which involves research on early detection and monitoring of cardiac injury due to cardiotoxicity. With a completion date of November 18, 2021, this small business set-aside...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency of the U.S. government. The contract, valued at $224,944.00, was awarded to Sibtech, Inc. on September 8, 2014 and has a completion date of December 7, 2015. The contract aims to develop specific molecular imaging agents that can be used in combination with existing imaging modalities to detect high-risk atherosclerotic plaque. This research...
This is a $97,680 firm fixed price contract awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract was set aside for small businesses and awarded to Mediomics LLC, a woman-owned small business. The contract is for the development of APTAMER-BASED PINCERS FOR CARDIOVASCULAR BIOMARKERS, which aligns with the National Heart Lung and Blood Institute's mission to support research on heart, lung, and blood...
<p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $279,113, was awarded to Gwathmey, Inc. on August 26, 2009 for biomedical (applied/exploratory) research. The contract has a firm fixed price pricing type and a completion date of September 30, 2010.</p>
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Aphios Corp, a minority-owned for-profit small business. The contract has a ceiling value of $149,440 and a completion date of December 14, 2011. It was awarded on June 15, 2011 under the SBIR program to support research related to Topic 43. SBIR contracts provide early-stage funding to small businesses for the development of innovative...
This contract award was made by the National Heart Lung and Blood Institute, a civilian agency, to Physical Optics Corporation, a small business, for a Phase I Small Business Innovation Research (SBIR) project focused on developing a cardiotoxicity biomarker sensing device. The contract has a firm fixed price of $236,370.00 and a period of performance from August 10, 2016 to August 9, 2017. Physical Optics Corporation is a small business that specializes in delivering advanced technology...
<p>This is a federal contract award from the National Heart Lung and Blood Institute, a civilian agency, to Biomedomics, Inc., a minority-owned, for-profit manufacturer of goods, for a Small Business Innovation Research (SBIR) Program Phase I research project. The contract has a Firm Fixed Price of $99,932.00 and was awarded on December 1, 2009 with a completion date of May 31, 2010. The contract is set aside for small businesses. No additional subcontractors or context are provided.</p>
This is a $1,591,490.86 Firm Fixed Price SBIR Phase I contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a civilian agency, to Collagen Medical LLC, a for-profit limited liability company, to support the development of target-specific molecular imaging agents in combination with existing imaging modalities to detect high-risk atherosclerotic plaque. The contract is set aside for small businesses. Collagen Medical has previously received federal grants from the National...
<p>This is a $201,498.00 Firm Fixed Price contract awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, to Inceptus Medical, LLC, a small business. The contract is for R&D under the SBIR Program Phase I and has a completion date of July 19, 2016. This is a definitive contract with no set-aside designation. The contract does not appear to be associated with a larger contract vehicle.</p>